Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00859261 · ClinicalTrials.gov registry record · NA

Two Dimensional (2D) Silicon Transducer-Compression Plates for Breast Ultrasound

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
21
Enrollment target

NCT00859261: Completed NA study, sponsored by University of Michigan.

NCT00859261 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00859261, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target

Study Summary

The study purpose is to help in the developement of 3 dimensional breast ultrasound imaging.

Primary Outcome

Assess the quality of 3 D ultrasound in comparison to conventional mammography

Interventions

  • PROCEDURE Experimental 3D Breast Ultrasound imaging
  • PROCEDURE Experimental Photoacoustic Imaging

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2009-03
Est. Completion 2015-02
Phase NA
University of Michigan

1,327 total trials

What the finished NCT00859261 record still lists

NCT00859261 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Experimental 3D Breast Ultrasound imaging is the first listed.

NCT00859261 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00859261 about?

NCT00859261 is a clinical study titled "Two Dimensional (2D) Silicon Transducer-Compression Plates for Breast Ultrasound". The study purpose is to help in the developement of 3 dimensional breast ultrasound imaging.

What is the current status of trial NCT00859261?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2009-03. Estimated completion is 2015-02.

What interventions are being tested in trial NCT00859261?

The interventions under investigation include: Experimental 3D Breast Ultrasound imaging (PROCEDURE), Experimental Photoacoustic Imaging (PROCEDURE).

Who is sponsoring clinical trial NCT00859261?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00859261's enrollment target sits among peer trials

21 1762nd of 2000 higher than 233 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02447874 · 21 participants · Phase 1

    Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

  • NCT03826992 · 21 participants · Phase 1

    Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

  • NCT04107077 · 21 participants · Phase 2

    Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

  • NCT04158635 · 21 participants · Phase 1

    Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00859261, the US trial registry maintained by the National Library of Medicine. NCT00859261 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.